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Introduction
E-PRE-DELIRIC is a point-of-admission ICU delirium
risk prediction tool [1], with reported good or moderate
performance [2–4]. In this study, we assessed its per-
formance in a large UK teaching hospital general ICU
using routinely collected data, as approved by the local
Research Data Governance Committee.
Methods
We retrospectively analysed data for 2445 consecutive
ICU admissions (November 2014 to June 2017). Patients
were routinely assessed for delirium, using twice daily
Confusion Assessment Method for the ICU (CAM-ICU)
assessment [5]. As in previous E-PRE-DELIRIC studies
[1–4], delirium was defined as any positive CAM-ICU
assessment or antipsychotic initiation while on ICU.
We adopted the original E-PRE-DELIRIC exclusion
criteria [1], excluding 683 ICU admissions for ICU stay
< 24 h (425 admissions), incomplete CAM-ICU data
(152), delirium on admission (50), comatose throughout
entire ICU stay (47), and age under 18 (9). Sixteen ad-
missions were excluded due to missing E-PRE-DELIRIC
components; 1746 admissions (1569 unique patients)
remained for analysis; this 71.4% inclusion rate is con-
sistent with previous studies (Table 1).
Results and discussion
Seven hundred sixty-three delirium cases were identified
(43.7% of ICU admissions), a higher incidence than re-
ported previously (Table 1). This is likely due to differ-
ences in the study population compared to previous
studies: more patients were classified as urgent, the
mean APACHE II score was higher, and median length
of stay (LoS) was longer (Table 1).
The mean E-PRE-DELIRIC score was 0.269 (Q1–Q3;
0.154–0.371). The histogram of E-PRE-DELIRIC scores
shows extensive overlap between patients who did and
did not develop delirium (Fig. 1a). The receiver operator
characteristic (ROC) curve (Fig. 1b) and the precision-
recall (PR) curve (Fig. 1c), showing precision (positive
predictive value (PPV)) against recall (sensitivity), both
indicate moderate-to-poor discriminative performance.
The area under the ROC (AUROC) was 0.628 (95% CI
0.602–0.653). The area under the PR curve (AUPRC)
was 0.534. For sensitivity > 0.1, PPV was between 0.437
and 0.585, indicating only around half of the patients
predicted to develop delirium actually did, in a popula-
tion with 43.7% incidence. Refitting the E-PRE-DELIRIC
logistic regression model to our data hardly improved
discrimination: AUROC was 0.648 (95% CI 0.622–0.673)
and AUPRC was 0.566.
The calibration plot, of predicted risk against observed
delirium rate, shows the risk of delirium is considerably
underestimated, especially in patients with predicted risk
of delirium less than 0.5 (Fig. 1d). Poor calibration is
corroborated by the calibration slope model logit(prob-
ability of delirium) = alpha + beta ×logit(p), where p is
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Table 1 Patient characteristics in this study, the E-PRE-DELIRIC development dataset [1] and other validation studies [2–4]
Factor This study Development dataset [1] DECISION study [2, 3] Green et al. [4]
Admissions during study period, n 2445 – 2802 803
Included in analysis, n (%) 1746 (71.4) 1962 (–) 2178 (77.7) 455 (56.7)
Delirium, n (%) 763 (43.7) 481 (24.5) 466 (21.4) 160 (35.2)
Age (years), mean (Q1–Q3, min/max) 58.6 (47.0–71.8, 18/94) 61.7 (53–74, 18/95) 62.1 (–) 66.7 (49.0–77.3, –/–)
Male, n (%) 1010 (57.8) 1166 (59.4) 1324 (60.8) 241 (53.0)
Admission category, n (%)
Surgery 813 (46.6) 1019 (51.9) 1079 (49.5) –
Medicine 837 (47.9) 683 (34.8) 859 (39.3) –
Trauma 33 (1.9) 90 (4.6) 86 (4.0) –
Neurology/neurosurgery 63 (3.6) 170 (8.7) 157 (7.2) –
Urgent admission, n (%) 1534 (87.9) 1163 (59.3) 1345 (61.8) –
APACHE II 20.0 (mean) – 17.4 (mean) 16 (median)
ICU LoS (days), median (Q1–Q3, min/max) 4.5 (2.4–10.0, 1.0/184.0) 2.0 (1–6, 1/133) 3.0 (2–6, 1/96) 2.6 (1.5–4.4, –/–)
ICU mortality, n (%) 210 (12.0) – – 17 (3.7)
– indicates the figure was not reported
Fig. 1 a Histogram of predicted risk of delirium by delirium status. b Receiver operator characteristic plot, with labels indicating the corresponding
threshold and the dashed line indicating the line of no discrimination. c Precision-recall plot, with the 43.7% observed incidence indicated by
the dashed line. d Calibration plot (with 95% CI), by tenths of predicted risk, with the dashed line indicating perfect calibration
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the E-PRE-DELIRIC score [6]. The estimated slope
beta = 0.58 (95% CI 0.46–0.71) is significantly below 1,
indicating the predicted probabilities are overly variable;
and the estimated intercept alpha = 0.84 (95% CI 0.74–
0.95) is significantly above 0 when fixing beta = 1, indi-
cating the predicted probabilities are predominantly too
low. E-PRE-DELIRIC is particularly poorly calibrated for
the surgical patients in the study, many of whom have
major intraabdominal pathology: those with predicted
risk < 10% had an observed incidence of 26%.
Of 763 delirium cases, 563 were CAM-ICU positive and
200 were included due to antipsychotic initiation. When in-
cluding only CAM-ICU-positive delirium, calibration was
improved (alpha = 0.29) but remained overly variable (beta =
0.52), while discrimination was similar (AUROC 0.615;
AUPRC 0.396, with 32.2% observed incidence).
While E-PRE-DELIRIC is intended as a point-of-
admission score, some of its exclusion criteria are retro-
spective (LoS; CAM-ICU completeness; comatose
throughout). To assess real-world performance, we re-
peated our analysis without these criteria. The AUROC
(0.615) and AUPRC (0.423, with 35.0% observed inci-
dence) remained similar.
Conclusion
In this population, the E-PRE-DELIRIC score is not as
discriminative or as well calibrated as previously re-
ported. PPV was only slightly higher than delirium inci-
dence, meaning the utility of E-PRE-DELIRIC for
guiding clinical decision-making in this population is
limited.
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